Cite
HARVARD Citation
Nashat, H. et al. (2020). A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study. International journal of cardiology. pp. 131-135. [Online].